Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02051933 · ClinicalTrials.gov registry record · NA
The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon Fractures
A NA study, sponsored by Wake Forest University Health Sciences.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02051933 is a NA study that was terminated before completion, run by Wake Forest University Health Sciences. The registered enrollment target is 10 participants.
The verdict
NCT02051933, a NA study, was terminated before completion, sponsored by Wake Forest University Health Sciences.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if botulinum toxin type A (Botox) injections, at the time of surgery for pilon fractures, will improve ankle range-of-motion and functionality.
Interventions
- DRUG Botulinum toxin type A
- DRUG sodium chloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-01 |
| Est. Completion | 2016-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02051933
The ClinicalTrials.gov registry entry for NCT02051933 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Botulinum toxin type A is the first listed.
NCT02051933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02051933 about?
NCT02051933 is a clinical study titled "The Effect of Botulinum Toxin A Injections on Ankle Dorsiflexion Following Internal Fixation of Tibial Pilon Fractures". The purpose of this study is to determine if botulinum toxin type A (Botox) injections, at the time of surgery for pilon fractures, will improve ankle range-of-motion and functionality.
What is the current status of trial NCT02051933?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2016-05.
What interventions are being tested in trial NCT02051933?
The interventions under investigation include: Botulinum toxin type A (DRUG), sodium chloride (DRUG).
Who is sponsoring clinical trial NCT02051933?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.